BI

Jan 07 2025HEALTH

Childhood Trauma and Suicidal Thoughts: Unraveling the Link in Iranian MDD Patients

Major Depressive Disorder, or MDD, is a serious mental health issue that impacts people worldwide. One of its most concerning symptoms is suicidal ideation. Many researchers have looked into how traumatic childhood events can lead to suicidal thoughts in adults. But not many studies have explored wh

reading time less than a minute
Jan 07 2025HEALTH

Life After Weight Loss Surgery: What Really Matters

Imagine you've just had bariatric surgery to help combat obesity and related health issues. You might be thinking, "Great! All my problems are solved. " But hold on a minute. This surgery isn't a magic solution that works the same way for everyone, especially if you have type 2 diabetes. What happen

reading time less than a minute
Jan 07 2025HEALTH

Healthcare Professionals' Views on Disabilities in Eastern India

In Eastern India, a significant number of people live with disabilities, and they often face health challenges that are not well met. This is partly because healthcare professionals might lack the right knowledge and understanding about disabilities. A recent study took a closer look at this issue i

reading time less than a minute
Jan 07 2025HEALTH

Sweet Drinks: The Tax Effect on Kids' Habits

Have you ever wondered how a tax on sugary drinks could influence kids' choices? Well, down in South Africa, researchers took a close look at this very topic. Over four years, they observed how a tax on sweet beverages, known as the health promotion levy, was changing kids' drinking habits. They did

reading time less than a minute
Jan 07 2025RELIGION

The Hidden Mothers: A Fresh Look at the Prodigal Son Story

For a long time, the parable of the Prodigal Son has been mostly focused on men like the father and the sons. But what if we look at it differently? Some historians think that the original listeners might have seen two important women in the story: the mother of the Prodigal Son and the mother of th

reading time less than a minute
Jan 07 2025TECHNOLOGY

Cloud Power: Boosting Static Analysis with Microsoft Azure

Have you ever wondered how cloud computing can supercharge static analysis? Well, let's dive into how Microsoft Azure is making a significant difference in this field. Researchers have been exploring the use of Azure to run the Static Driver Verifier (SDV), a tool designed to check the safety of dev

reading time less than a minute
Jan 07 2025HEALTH

Boosting Cancer Treatment: LAG-3's Role in Biliary Tract Cancer

Imagine you're battling advanced biliary tract cancer (ABTC), and your doctors suggest a mix of drugs: nivolumab, modified gemcitabine, and S-1. This combo showed promise in a past trial, but PD-L1 levels didn't tell us much about how well it would work. So, scientists looked at another marker, LAG-

reading time less than a minute
Jan 07 2025HEALTH

Timing of Cancer Drug Infusions: Does It Matter?

You might not think about it, but the time of day you get your cancer treatment could make a difference. Scientists have been looking into how our body's internal clock, called the circadian rhythm, affects how well cancer drugs work. One type of drug, called immune checkpoint inhibitors (ICIs), has

reading time less than a minute
Jan 07 2025HEALTH

Predicting Who Responds to Immunotherapy in Advanced Biliary Cancer

Immune treatments, or immune checkpoint inhibitors (ICIs), are game-changers for some people with far-advanced solid tumors. But when it comes to biliary tract cancer (BTC), doctors are still figuring out who gets the most benefit from these treatments. A recent trial focused on pembrolizumab, an IC

reading time less than a minute
Jan 07 2025HEALTH

Lymphocyte-Monocyte Ratio: A Game Changer for Biliary Tract Cancer?

Biliary tract cancers, like cholangiocarcinoma and gallbladder cancer, are growing more common worldwide, and most patients get diagnosed when the disease has already advanced, leading to a grim outlook. Recently, combining immune checkpoint inhibitors, such as durvalumab and pembrolizumab, with the

reading time less than a minute